RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ViroGates A/S Stock

ViroGates A/S Equity 2024

ViroGates A/S Equity

17.01 M DKK

Ticker

VIRO.CO

ISIN

DK0061030574

In 2024, ViroGates A/S's equity was 17.01 M DKK, a 5.71% increase from the 16.09 M DKK equity in the previous year.

ViroGates A/S Aktienanalyse

What does ViroGates A/S do?

ViroGates A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing ViroGates A/S's Equity

ViroGates A/S's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding ViroGates A/S's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating ViroGates A/S's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

ViroGates A/S's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in ViroGates A/S’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about ViroGates A/S stock

What is the equity of ViroGates A/S this year?

ViroGates A/S has equity of 17.01 M DKK this year.

What was the equity of ViroGates A/S compared to the previous year?

The equity of ViroGates A/S has increased/decreased by 5.71% increased compared to the previous year.

What impact does a high equity have on investors of ViroGates A/S?

A high equity is advantageous for investors of ViroGates A/S as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of ViroGates A/S?

A low equity can be a risk for investors of ViroGates A/S, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of ViroGates A/S affect the company?

An increase in equity of ViroGates A/S can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of ViroGates A/S affect the company?

A reduction in equity of ViroGates A/S can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of ViroGates A/S?

Some factors that can affect the equity of ViroGates A/S include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of ViroGates A/S so important for investors?

The equity of ViroGates A/S is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can ViroGates A/S take to change the equity?

To change equity, ViroGates A/S can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does ViroGates A/S pay?

Over the past 12 months, ViroGates A/S paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ViroGates A/S is expected to pay a dividend of 0 DKK.

What is the dividend yield of ViroGates A/S?

The current dividend yield of ViroGates A/S is .

When does ViroGates A/S pay dividends?

ViroGates A/S pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ViroGates A/S?

ViroGates A/S paid dividends every year for the past 0 years.

What is the dividend of ViroGates A/S?

For the upcoming 12 months, dividends amounting to 0 DKK are expected. This corresponds to a dividend yield of 0 %.

In which sector is ViroGates A/S located?

ViroGates A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von ViroGates A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ViroGates A/S from 12/21/2024 amounting to 0 DKK, you needed to have the stock in your portfolio before the ex-date on 12/21/2024.

When did ViroGates A/S pay the last dividend?

The last dividend was paid out on 12/21/2024.

What was the dividend of ViroGates A/S in the year 2023?

In the year 2023, ViroGates A/S distributed 0 DKK as dividends.

In which currency does ViroGates A/S pay out the dividend?

The dividends of ViroGates A/S are distributed in DKK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ViroGates A/S

Our stock analysis for ViroGates A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ViroGates A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.